Tilray, Inc. Series 2 Aktie News

Tilray Brands won't be generating more cash than it spends this year. It had previously advised investors to expect the opposite.

Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many are wondering about the status of cannabis stocks as a whole. Cannabis stocks, as a whole, spiked upwards on the news but quickly reverted to pre-announcement norms.

Investors should not get overly excited about President Biden's decision to reclassify marijuana. The potential move toward becoming a less dangerous schedule 3 drug is lengthy and will not result in cannabis becoming federally legal.

Solei's New Cannabis-Infused Topical Solution is Made for Active Lifestyle Enthusiasts Solei's New Cannabis-Infused Topical Solution is Made for Active Lifestyle Enthusiasts

TLRY stock pulled back after a recent jump on cannabis reclassification news. So is now the time to buy?

Most major stock market indices are green for the year. Even cannabis stocks, which struggled last year, have rallied almost across the board.

Penny stocks are a horrible investment. Selling for less than $1 per share, penny stocks are cheap for a reason.

Tilray Brands Inc. is getting ready for marijuana to be reclassified as a less dangerous drug in the U.S., as the cannabis company is looking to raise money through the sale of shares so it can expand.